Systane | United States

This page is available in English. Select below for other countries.

Select other country

SYSTANE® ICAPS® Eye Vitamin AREDS 2 Formula

(softgels)

 

This item may have limited stock availability due to discontinuation.


Explore other eye care products below.

 

AREDS 2 Eye Vitamin

 

SYSTANE® ICAPS® Eye Vitamin AREDS 2 Formula contains ingredients used in the Age-Related Eye Disease Study 2 (AREDS 2) conducted by the National Eye Institute to support eye health in people with Age-Related Macular Degeneration (AMD)*. 

 

*This statement has not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat or prevent any disease.

Systane ICAPS AREDS 2 eye vitamin and mineral supplement softgels product box by Alcon

Other Systane® Products

Systane Complete Preservative-Free Lubricant Eye Drops product box by Alcon
Systane Complete Preservative-Free Lubricant Eye Drops product box by Alcon

Systane® COMPLETE
Preservative-Free Eye Drops

 

Our most advanced dry eye solution with 8 hours of symptom relief1 in a preservative-free formula ideal for sensitive eyes.

 

*vs SYSTANE® BALANCE

 

LEARN MORE

GET COUPON

Systane Nighttime Severe Dry Eye Relief Eye Ointment tube and product box by Alcon
Systane Nighttime Severe Dry Eye Relief Eye Ointment tube and product box by Alcon

Systane® Nighttime Eye Ointment

 

Designed to keep your eyes lubricated and comfortable at night.

 

LEARN MORE

GET COUPON

Product Details

 

  1. Helps preserve healthy vision*
  • No added beta carotene**
  • Also available in chewables
  • The high levels of vitamin C, vitamin E and zinc found in SYSTANE® ICAPS® Eye Vitamin AREDS 2 Formula generally can be attained only by supplement and not through diet alone.

 

*This statement has not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat or prevent any disease.
**May contain trace amounts from natural sources

Woman with short brown hair and brown eyes smiling

SYSTANE® ICAPS® Eye Vitamin AREDS 2 Formula FAQs 

    No. ICAPS® soft gels are designed to be taken whole.

    Yes

    Consult your eye care professional to determine which SYSTANE® ICAPS® formulation would be best suited for your particular needs.

    ICAPS® are not made with gluten.

    Drug Facts

      Two softgels daily; 1 in the morning and 1 in the evening with meals or as directed by your physician. 

      Ingredients:

      Vitamin C (as ascorbic acid & sodium ascorbate)

      Vitamin E (as d-alpha-tocopherol acetate)

      Zinc (as zinc oxide)

      Copper (as copper citrate)

      Lutein

      Zeaxanthin

       

      Other ingredients: Gelatin, Soybean Oil, Glycerol, Purified Water, Yellow Beeswax, Silicone Dioxide, Caramel Powder, Lecithin (soybean)

      Do not use if safety seal under cap is broken or missing.
      Softgels should be consumed whole. Do not consume damaged softgels.
      If you are taking prescription medications or are being treated for a medical condition, you should consult your healthcare professional before taking this (or any) dietary supplement.

       

      Keep out of reach of children.

       

      Store at room temperature in a dry place with the lid tightly closed.

      For ocular use only.

       

      If solution changes color or becomes cloudy, do not use.

       

      To avoid contamination, never touch the dropper tip of the container to any surface. 

       

      Replace cap after using.

       

      Stop using and consult your eye care professional if you experience:

      • Persistent eye discomfort, 
      • Vision changes, 
      • Excessive tearing, 
      • Redness of the eye

       

      Keep out of reach of children. If swallowed, get medical help.

      Facebook Icon Instagram icon

      References

       

      1. Silverstein S, Yeu E, Tauber J, et al. Symptom Relief Following a Single Dose of Propylene Glycol-Hydroxypropyl Guar Nanoemulsion in Patients with Dry Eye Disease: A Phase IV, Multicenter Trial. Clin Ophthalmol. 2020;14:3167-3177.